Overview HD12 for Advanced Stages Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary This study is designed to test (1) whether the BEACOPP dosage can be reduced to baseline in the last 4 cycles without loss of effectiveness, and (2) whether consolidating irradiation is necessary following effective chemotherapy. Phase: Phase 3 Details Lead Sponsor: University of CologneTreatments: BleomycinCyclophosphamideDoxorubicinEtoposideLiposomal doxorubicinPrednisoneProcarbazineVincristine